IDH2 and neoplasm: According to National Comprehensive Cancer Network guidelines, the prognostic values of age (≤40 years vs. >40 years), tumor grade (II vs. III), and IDH status (wild-type vs. mutation) have been well-established in clinical practice (National Comprehensive Cancer Network, 2019).